Astonea Labs Ltd. (ASTONEALAB): Astonea Labs Share Price rises 9.7% to Rs 294
- September 7, 2026
- Posted by: Harsh Piplani
- Category: News
Astonea Labs Share Price is trading at Rs 294, up 9.7% today, with market capitalisation at Rs 281.69 crore. The move places Astonea Labs Ltd. in focus on Univest as a notable stock gain within the Indian stock market, even though the latest data confirms the price event but does not establish a company-specific catalyst. For investors tracking Astonea Labs Share Price Today, the key question is how the stock’s valuation and business context compare with the broader healthcare space. According to latest Univest data, the current move follows a start at Rs 275, a touch of Rs 294 and turnover of Rs 0.09 crore. Univest readers can monitor whether today’s stock news is supported by follow-through in price action, business performance and sector relative positioning.
Astonea Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 294 |
| Previous Close | Rs 268 |
| Today's Move | Rs 26 (+9.7%) |
| Open | Rs 275 |
| High | Rs 294 |
| Low | Rs 275 |
| Turnover | Rs 0.09 crore |
| Market Capitalisation | Rs 281.69 crore |
| Market Cap Category | Micro Cap |
Astonea Labs Ltd. (ASTONEALAB) rose to Rs 294 from the previous close of Rs 268, a move of Rs 26 or 9.7%. The stock opened at Rs 275, reached a high of Rs 294, recorded a low of Rs 275.
Astonea Labs Share Price moved from the previous close of Rs 268 to Rs 294, a rise of Rs 26 or 9.7%. The stock opened at Rs 275 and traded between Rs 275 and Rs 294, with the latest trade also matching the day’s high. This makes Astonea Labs Stock News relevant for traders looking at a clean price rise rather than a broad market story. The move also stands out in Stock Market Today discussions because the stock is now higher than its previous close by a meaningful margin, while turnover remained Rs 0.09 crore. For readers scanning Astonea Labs Share Price Live updates on Univest, the immediate takeaway is that price action has been firm, but the latest numbers alone do not identify the reason behind the rise.
Astonea Labs Ltd. (ASTONEALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 281.69 crore |
| P/E Ratio | 62.39x |
| P/B Ratio | 4.93x |
| ROE | 11.95% |
| ROCE | 10.51% |
| EPS | Rs 4.3 |
| Book Value Per Share | Rs 54.35 |
| Dividend Yield | 0% |
Astonea Labs Ltd. (ASTONEALAB) fundamental metrics show P/E 62.39x, P/B 4.93x, ROE 11.95%, ROCE 10.51%. These figures provide context only and are not a buy or sell signal.
Astonea Labs Ltd. has a market capitalisation of Rs 281.69 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.39x, P/B at 4.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.95% and ROCE of 10.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.3, book value per share of Rs 54.35, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 62.39x |
| Benchmark Median P/E | 32.83x |
| Benchmark Average P/E | 48.79x |
| Benchmark P/E Range | 3.2x to 659.73x |
| Company P/B Ratio | 4.93x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 11.95% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 10.51% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 281.69 crore |
| Benchmark Median Market Cap | Rs 674.09 crore |
Astonea Labs Ltd. (ASTONEALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Astonea Labs Ltd. (ASTONEALAB) has a P/E ratio of 62.39x, which is above the benchmark median of 32.83x, a difference of +90.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astonea Labs Ltd. (ASTONEALAB) has a ROE of 11.95%, which is above the benchmark median of 11.78%, a difference of +1.44%. Astonea Labs Ltd. (ASTONEALAB) has a ROCE of 10.51%, which is below the benchmark median of 13.65%, a difference of -23%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,633.71 | 37.67 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,576.41 | 82.59 | 13.68 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.58 | 20.55 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.19 | 3.18 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,820.18 | 24.78 | 4.15 | 19.69 | 21.39 |
Astonea Labs Ltd. (ASTONEALAB) has a P/E ratio of 62.39x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.95% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.51% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Astonea Labs Ltd. (ASTONEALAB) has a market capitalisation of Rs 281.69 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Astonea Labs
- Astonea Labs Share Price rose 9.7% to Rs 294, making it a clear market mover today.
- The stock traded at the day’s high of Rs 294 after opening at Rs 275.
- P/E of 62.39 and P/B of 4.93 keep valuation in focus for Astonea Labs Stock News.
- ROE of 11.95% and ROCE of 10.51% provide the current profitability backdrop.
- Healthcare sector and Pharmaceuticals & Drugs industry positioning keeps Astonea Labs Share Price relevant for sector watchlists.
About Astonea Labs Ltd.
Astonea Labs Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector, which places Astonea Labs Share Price in a category that often attracts valuation-led attention. The company’s market profile, as reflected by its Rs 281.69 crore market cap, suggests a smaller listed business within a wide industry set. For readers following Astonea Labs Share Price Today on Univest, the main business question is not just where the stock trades, but how the company’s financial ratios and industry position fit into the broader healthcare market. EPS of Rs 4.3, book value of Rs 54.35 and ROE of 11.95% provide a basic snapshot of operating context, while ROCE of 10.51% helps frame capital efficiency. That combination makes Astonea Labs Stock News relevant for investors who compare small-cap healthcare names on both price and fundamentals.
Frequently Asked Questions
Why did Astonea Labs Share Price rise today?
Ans. The latest market data confirms Astonea Labs Share Price rose 9.7% to Rs 294, but it does not establish a company-specific catalyst. The stock’s move is therefore best read as price action first.
What is the current Astonea Labs Share Price?
Ans. Astonea Labs Share Price is Rs 294. It traded above the previous close of Rs 268 and touched the day’s high of Rs 294, keeping the stock in focus on Univest.
How much did Astonea Labs Share Price gain today?
Ans. Astonea Labs Share Price gained Rs 26, or 9.7%, today. The move came after an opening level of Rs 275, and the latest trade matched the day’s high of Rs 294.
What is Astonea Labs market capitalisation?
Ans. Astonea Labs has a market capitalisation of Rs 281.69 crore. That places it in the small-cap range and helps investors frame the stock’s scale alongside its current price movement.
Is Astonea Labs Share Price expensive on valuation?
Ans. Astonea Labs trades at a P/E of 62.39 and a P/B of 4.93. Both are above the same-industry median, so the stock looks priced at a premium versus many healthcare peers.
How do Astonea Labs fundamentals look today?
Ans. The company reports ROE of 11.95%, ROCE of 10.51%, EPS of Rs 4.3 and book value of Rs 54.35. These figures provide context, but valuation remains the sharper market focus.
Which sector does Astonea Labs belong to?
Ans. Astonea Labs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That context matters because peer valuation, return ratios and market cap are usually compared within this industry set.
How can investors track Astonea Labs Share Price on Univest?
Ans. Investors can track Astonea Labs Share Price on Univest for live price updates, fundamental ratios, market cap, sector context and peer comparison. It is a useful starting point for stock news monitoring.
Track Astonea Labs Share Price on Univest
Use Astonea Labs Ltd. (ASTONEALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Astonea Labs Share Price on Univest for live price updates, market cap, fundamental ratios, sector context and peer comparison. Univest also helps readers follow Astonea Labs Share Price Today with a broader stock analysis view that brings together company facts, valuation context and market moves in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
